Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
32.847 (90/274) |
7.76E-30 |
Serine/threonine-protein kinase 26 (STK26)
|
|
29.804 (76/255) |
3.30E-27 |
Serine/threonine-protein kinase 24 (STK24)
|
|
29.278 (77/263) |
1.74E-25 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
29.907 (64/214) |
1.88E-23 |
PAK-2 protein kinase (PAK2)
|
|
30.882 (63/204) |
1.97E-23 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
30.986 (66/213) |
3.47E-23 |
Serine/threonine-protein kinase 25 (STK25)
|
|
28.030 (74/264) |
8.76E-23 |
Serine/threonine-protein kinase MAK (MAK)
|
|
29.907 (64/214) |
1.12E-22 |
Omphalocele kinase 1 (NUAK1)
|
|
29.825 (68/228) |
1.21E-22 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
26.744 (69/258) |
1.97E-22 |
Oxidative stress responsive 1 (OXSR1)
|
|
29.577 (84/284) |
1.99E-22 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
29.902 (61/204) |
2.15E-22 |
NIMA-related kinase 6 (NEK6)
|
|
25.874 (74/286) |
2.30E-22 |
Ste-20-related kinase (STK39)
|
|
30.282 (86/284) |
3.73E-22 |
PAK-1 protein kinase (PAK1)
|
|
29.902 (61/204) |
3.98E-22 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
30.986 (66/213) |
5.63E-22 |
MST-1 protein kinase (STK4)
|
|
28.571 (76/266) |
5.91E-22 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
28.063 (71/253) |
1.07E-21 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
28.571 (72/252) |
1.48E-21 |
Serine/threonine-protein kinase 3 (STK3)
|
|
28.846 (75/260) |
1.89E-21 |
Myosin light chain kinase 2 (MYLK2)
|
|
29.224 (64/219) |
1.94E-21 |
Polo-like kinase 1 (PLK1)
|
|
30.488 (75/246) |
2.81E-21 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
28.016 (72/257) |
2.90E-21 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
30.882 (63/204) |
3.75E-21 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
31.980 (63/197) |
3.84E-21 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
28.514 (71/249) |
3.99E-21 |
NIMA-related kinase 7 (NEK7)
|
|
25.532 (72/282) |
4.53E-21 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
25.882 (66/255) |
8.59E-21 |
Serine/threonine-protein kinase 33 (STK33)
|
|
30.435 (70/230) |
1.32E-20 |
Salt-inducible kinase 1 (SIK1)
|
|
29.921 (76/254) |
1.35E-20 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
29.921 (76/254) |
1.36E-20 |
Fused homolog (STK36)
|
|
28.916 (72/249) |
1.59E-20 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
29.902 (61/204) |
1.74E-20 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
23.346 (60/257) |
2.02E-20 |
Polo-like kinase 2 (PLK2)
|
|
29.339 (71/242) |
2.87E-20 |
MEK kinase kinase 3 (MAP4K3)
|
|
28.676 (78/272) |
5.18E-20 |
Salt-inducible kinase 2 (SIK2)
|
|
30.556 (66/216) |
5.87E-20 |
Polo-like kinase 4 (PLK4)
|
|
28.516 (73/256) |
6.34E-20 |
Unc-51 like kinase 3 (ULK3)
|
|
28.090 (75/267) |
7.82E-20 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
28.044 (76/271) |
8.20E-20 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
28.319 (64/226) |
1.00E-19 |
MEK kinase kinase 1 (MAP4K1)
|
|
28.185 (73/259) |
1.45E-19 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
28.251 (63/223) |
2.94E-19 |
Cyclin-dependent kinase 3 (CDK3)
|
|
30.045 (67/223) |
3.33E-19 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
26.374 (72/273) |
4.03E-19 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
28.958 (75/259) |
5.44E-19 |
Aurora kinase C (AURKC)
|
|
28.571 (70/245) |
6.64E-19 |
Cyclin-dependent kinase 2 (CDK2)
|
|
29.032 (63/217) |
8.03E-19 |
Stress-activated protein kinase 2b (p38 beta)
|
|
29.707 (71/239) |
9.30E-19 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
27.381 (69/252) |
1.48E-18 |
ERK activator kinase 5 (MAP2K5)
|
|
30.242 (75/248) |
2.08E-18 |
PAK-4 protein kinase (PAK4)
|
|
27.344 (70/256) |
2.57E-18 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
25.984 (66/254) |
2.72E-18 |
NIMA-related kinase 1 (NEK1)
|
|
22.656 (58/256) |
4.68E-18 |
Protein kinase C theta (PRKCQ)
|
|
27.174 (75/276) |
5.06E-18 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
27.692 (72/260) |
7.23E-18 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
28.182 (62/220) |
8.28E-18 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
26.792 (71/265) |
1.11E-17 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
28.870 (69/239) |
1.72E-17 |
Protein kinase C epsilon (PRKCE)
|
|
28.241 (61/216) |
1.85E-17 |
Serine/threonine-protein kinase cot (COT)
|
|
32.296 (83/257) |
1.97E-17 |
Doublecortin-like kinase 1 (DCLK1)
|
|
25.806 (56/217) |
2.07E-17 |
Cyclin-dependent kinase 1 (CDK1)
|
|
26.457 (59/223) |
2.18E-17 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
32.039 (66/206) |
2.21E-17 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
29.630 (64/216) |
2.49E-17 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
28.685 (72/251) |
3.04E-17 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
31.683 (64/202) |
3.21E-17 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
27.160 (66/243) |
3.57E-17 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
29.187 (61/209) |
3.79E-17 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
27.823 (69/248) |
3.92E-17 |
SIK family kinase 3 (SIK3)
|
|
28.378 (63/222) |
4.35E-17 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
25.806 (64/248) |
5.12E-17 |
Misshapen-like kinase 1 (MINK1)
|
|
26.222 (59/225) |
5.30E-17 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
25.448 (71/279) |
6.93E-17 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
26.087 (66/253) |
9.32E-17 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
31.336 (68/217) |
9.99E-17 |
Testis-specific serine kinase 2 (TSSK2)
|
|
27.273 (66/242) |
1.31E-16 |
MEK kinase kinase 2 (MAP4K2)
|
|
25.271 (70/277) |
1.53E-16 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
31.050 (68/219) |
1.66E-16 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
29.798 (59/198) |
1.96E-16 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
27.626 (71/257) |
2.70E-16 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
29.148 (65/223) |
3.14E-16 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
29.482 (74/251) |
3.44E-16 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
29.384 (62/211) |
4.63E-16 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
30.252 (72/238) |
4.66E-16 |
Aurora kinase A (AURKA)
|
|
26.357 (68/258) |
6.12E-16 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
24.627 (66/268) |
6.58E-16 |
Cyclin-dependent kinase 15 (CDK15)
|
|
30.542 (62/203) |
7.19E-16 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
29.044 (79/272) |
7.25E-16 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
33.136 (56/169) |
7.82E-16 |
Protein kinase C delta (PRKCD)
|
|
29.646 (67/226) |
9.08E-16 |
MEK kinase kinase 4 (MAP4K4)
|
|
26.601 (54/203) |
1.10E-15 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
28.643 (57/199) |
1.26E-15 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
24.400 (61/250) |
1.35E-15 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
28.700 (64/223) |
1.41E-15 |
BR serine/threonine kinase 2 (BRSK2)
|
|
27.948 (64/229) |
1.43E-15 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
29.798 (59/198) |
1.59E-15 |
Myosin light kinase (MYLK)
|
|
26.389 (57/216) |
1.78E-15 |
Cyclin-dependent kinase 5 (CDK5)
|
|
26.190 (55/210) |
2.41E-15 |
Doublecortin-like kinase 3 (DCLK3)
|
|
26.582 (63/237) |
3.05E-15 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
30.303 (60/198) |
3.27E-15 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
25.498 (64/251) |
3.43E-15 |
Protein kinase D (PRKD1)
|
|
28.788 (57/198) |
3.68E-15 |
Cyclin-dependent kinase 6 (CDK6)
|
|
29.439 (63/214) |
3.77E-15 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
29.362 (69/235) |
3.79E-15 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
30.357 (68/224) |
3.99E-15 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
29.520 (80/271) |
4.06E-15 |
BR serine/threonine kinase 1 (BRSK1)
|
|
26.829 (66/246) |
5.79E-15 |
Cyclin-dependent kinase 13 (CDK13)
|
|
27.650 (60/217) |
6.60E-15 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
28.159 (78/277) |
7.61E-15 |
NIMA-related kinase 2 (NEK2)
|
|
28.947 (55/190) |
7.85E-15 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
30.870 (71/230) |
8.46E-15 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
26.230 (64/244) |
8.97E-15 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
27.243 (82/301) |
1.01E-14 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
28.413 (77/271) |
1.02E-14 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
27.273 (54/198) |
1.13E-14 |
Death-associated protein kinase 3 (DAPK3)
|
|
25.234 (54/214) |
1.20E-14 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
27.426 (65/237) |
1.31E-14 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
25.943 (55/212) |
1.32E-14 |
Cyclin-dependent kinase 17 (CDK17)
|
|
27.751 (58/209) |
1.35E-14 |
Cytoplasmic DRAK1 (STK17A)
|
|
26.941 (59/219) |
1.38E-14 |
Myosin light chain kinase 3 (MYLK3)
|
|
29.268 (60/205) |
1.45E-14 |
Cyclin-dependent kinase 16 (CDK16)
|
|
25.116 (54/215) |
1.54E-14 |
ERK activator kinase 1 (MEK1)
|
|
29.048 (61/210) |
1.90E-14 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
27.803 (62/223) |
2.03E-14 |
Cyclin-dependent kinase 12 (CDK12)
|
|
27.027 (60/222) |
2.31E-14 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
26.761 (57/213) |
2.43E-14 |
Checkpoint kinase-1 (CHK1)
|
|
29.187 (61/209) |
2.45E-14 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
27.679 (62/224) |
2.59E-14 |
Protein kinase C beta (PRKCB)
|
|
24.074 (52/216) |
2.60E-14 |
Serine/threonine-protein kinase NLK (NLK)
|
|
28.000 (56/200) |
2.60E-14 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
27.053 (56/207) |
2.69E-14 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
26.908 (67/249) |
3.09E-14 |
ERK activator kinase 2 (MEK2)
|
|
29.515 (67/227) |
3.28E-14 |
Nik-related protein kinase (NRK)
|
|
25.911 (64/247) |
3.94E-14 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
29.204 (66/226) |
4.00E-14 |
Myosin-IIIa (MYO3A)
|
|
25.180 (70/278) |
6.24E-14 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
24.800 (62/250) |
6.44E-14 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
28.713 (58/202) |
6.60E-14 |
Doublecortin-like kinase 2 (DCLK2)
|
|
23.377 (54/231) |
7.23E-14 |
Protein kinase G1 (PRKG1)
|
|
25.498 (64/251) |
7.63E-14 |
TAO kinase 1 (TAOK1)
|
|
30.622 (64/209) |
7.86E-14 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
28.378 (63/222) |
8.69E-14 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
28.512 (69/242) |
9.19E-14 |
Cyclin-dependent kinase 7 (CDK7)
|
|
28.372 (61/215) |
1.03E-13 |
Death-associated protein kinase 2 (DAPK2)
|
|
23.629 (56/237) |
1.15E-13 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
29.327 (61/208) |
1.30E-13 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
27.206 (74/272) |
1.31E-13 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
22.892 (57/249) |
1.77E-13 |
Cyclin-dependent kinase 20 (CDK20)
|
|
25.455 (56/220) |
1.81E-13 |
Aurora kinase B (AURKB)
|
|
26.563 (68/256) |
1.84E-13 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
28.916 (72/249) |
1.94E-13 |
Death-associated protein kinase 1 (DAPK1)
|
|
26.724 (62/232) |
2.09E-13 |
CaM-kinase IV kinase (CAMKK1)
|
|
31.395 (54/172) |
2.19E-13 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
27.731 (66/238) |
2.38E-13 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
24.514 (63/257) |
2.50E-13 |
Protein kinase N3 (PKN3)
|
|
28.058 (78/278) |
2.90E-13 |
STE20-related kinase adapter protein beta (STRADB)
|
|
26.721 (66/247) |
3.71E-13 |
Protein kinase C alpha (PRKCA)
|
|
23.148 (50/216) |
4.12E-13 |
Protein kinase C eta type (PRKCH)
|
|
24.651 (53/215) |
4.79E-13 |
Cyclin-dependent kinase 18 (CDK18)
|
|
27.103 (58/214) |
5.47E-13 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
24.314 (62/255) |
5.82E-13 |
Protein kinase C gamma (PRKCG)
|
|
25.676 (57/222) |
9.22E-13 |
Serine/threonine-protein kinase 10 (STK10)
|
|
27.402 (77/281) |
9.82E-13 |
Protein kinase G2 (PRKG2)
|
|
25.200 (63/250) |
1.07E-12 |
NF-kappa-B-activating kinase (TBK1)
|
|
29.808 (62/208) |
1.10E-12 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
22.177 (55/248) |
1.14E-12 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
27.854 (61/219) |
1.15E-12 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
25.701 (55/214) |
1.33E-12 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
28.936 (68/235) |
1.39E-12 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
22.917 (55/240) |
1.41E-12 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
29.386 (67/228) |
1.42E-12 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
27.451 (70/255) |
1.46E-12 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
32.161 (64/199) |
1.67E-12 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
23.790 (59/248) |
1.93E-12 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
22.624 (50/221) |
2.00E-12 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
24.615 (48/195) |
2.10E-12 |
Obscurin (OBSCN)
|
|
31.544 (47/149) |
2.12E-12 |
Cyclin-dependent kinase 4 (CDK4)
|
|
36.000 (36/100) |
2.23E-12 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
24.464 (57/233) |
2.40E-12 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
29.630 (64/216) |
2.71E-12 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
28.111 (61/217) |
4.19E-12 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
29.630 (64/216) |
4.36E-12 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
27.273 (54/198) |
4.41E-12 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
26.906 (60/223) |
4.72E-12 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
29.032 (54/186) |
5.37E-12 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
26.906 (60/223) |
6.07E-12 |
TGF-beta receptor type I (TGFBR1)
|
|
25.455 (56/220) |
6.16E-12 |
Cyclin-dependent kinase 9 (CDK9)
|
|
25.571 (56/219) |
8.19E-12 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
28.571 (74/259) |
8.36E-12 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
25.581 (55/215) |
8.42E-12 |
Protein kinase N2 (PKN2)
|
|
26.275 (67/255) |
9.12E-12 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
22.624 (50/221) |
9.23E-12 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
24.911 (70/281) |
1.07E-11 |
TAO kinase 3 (TAOK3)
|
|
28.185 (73/259) |
1.09E-11 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
23.529 (48/204) |
1.18E-11 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
24.242 (56/231) |
1.54E-11 |
CDC-like kinase 3 (CLK3)
|
|
24.490 (60/245) |
2.40E-11 |
Activin receptor type IB (ACVR1B)
|
|
23.729 (70/295) |
2.80E-11 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
25.175 (72/286) |
2.82E-11 |
Cyclin-dependent kinase 14 (CDK14)
|
|
26.108 (53/203) |
3.25E-11 |
Myosin-IIIb (MYO3B)
|
|
24.000 (66/275) |
3.67E-11 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
24.809 (65/262) |
3.88E-11 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
28.750 (69/240) |
4.15E-11 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
27.174 (50/184) |
4.30E-11 |
ERK activator kinase 7 (MAP2K7)
|
|
25.670 (67/261) |
4.34E-11 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
25.481 (53/208) |
5.25E-11 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
24.675 (57/231) |
6.36E-11 |
MAP kinase p38 (MAPK12)
|
|
25.714 (54/210) |
7.29E-11 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
25.229 (55/218) |
8.65E-11 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
25.962 (54/208) |
9.74E-11 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
22.989 (80/348) |
1.03E-10 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
28.155 (58/206) |
1.11E-10 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
25.000 (50/200) |
1.28E-10 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
25.991 (59/227) |
1.52E-10 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
30.808 (61/198) |
1.54E-10 |
Tau-tubulin kinase 2 (TTBK2)
|
|
25.540 (71/278) |
1.79E-10 |
Cyclin-dependent kinase 10 (CDK10)
|
|
31.019 (67/216) |
1.81E-10 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
24.364 (67/275) |
1.92E-10 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
25.352 (72/284) |
1.99E-10 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
25.521 (49/192) |
2.10E-10 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
27.273 (57/209) |
2.11E-10 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
24.255 (57/235) |
2.55E-10 |
Titin (TTN)
|
24.880 (52/209) |
2.60E-10 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
24.675 (57/231) |
2.65E-10 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
23.902 (49/205) |
2.70E-10 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
26.490 (40/151) |
3.99E-10 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
24.651 (53/215) |
4.15E-10 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
23.913 (55/230) |
4.75E-10 |
Yet another novel kinase 2 (STK32B)
|
|
26.872 (61/227) |
5.10E-10 |
Casein kinase I isoform alpha-like (CSNK1A1L)
|
|
25.632 (71/277) |
5.21E-10 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
31.304 (36/115) |
5.41E-10 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
23.913 (55/230) |
5.75E-10 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
26.087 (42/161) |
6.01E-10 |
PDZ binding kinase (PBK)
|
|
24.390 (60/246) |
6.68E-10 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
23.832 (51/214) |
6.76E-10 |
Casein kinase I delta (CSNK1D)
|
|
26.449 (73/276) |
7.29E-10 |
Casein kinase I epsilon (CSNK1E)
|
|
26.087 (72/276) |
7.38E-10 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
27.632 (63/228) |
7.57E-10 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
23.721 (51/215) |
8.36E-10 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
28.571 (60/210) |
8.52E-10 |
Tau-tubulin kinase (TTBK1)
|
|
25.862 (60/232) |
8.75E-10 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
22.845 (53/232) |
9.83E-10 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
24.887 (55/221) |
1.11E-09 |
Cyclin-dependent kinase 19 (CDK19)
|
|
26.415 (56/212) |
1.24E-09 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
32.692 (34/104) |
1.37E-09 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
23.980 (47/196) |
1.38E-09 |
Membrane-associated kinase (PKMYT1)
|
|
25.893 (58/224) |
1.71E-09 |
NDR1 protein kinase (STK38)
|
|
22.441 (57/254) |
2.07E-09 |
NDR2 protein kinase (STK38L)
|
|
21.479 (61/284) |
2.31E-09 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
24.497 (73/298) |
4.32E-09 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
31.288 (51/163) |
4.73E-09 |
BMP-2-inducible protein kinase (BMP2K)
|
|
25.556 (69/270) |
4.91E-09 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
24.670 (56/227) |
5.22E-09 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
24.629 (83/337) |
5.78E-09 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
28.994 (49/169) |
7.63E-09 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
26.316 (55/209) |
1.02E-08 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
23.661 (53/224) |
1.02E-08 |
Protein kinase N1 (PKN1)
|
|
26.364 (58/220) |
1.16E-08 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
25.510 (50/196) |
1.49E-08 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
25.746 (69/268) |
1.71E-08 |
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
26.389 (57/216) |
1.89E-08 |
Casein kinase I alpha (CSNK1A1)
|
|
25.632 (71/277) |
1.89E-08 |
Rho-associated protein kinase 1 (ROCK1)
|
|
23.721 (51/215) |
1.97E-08 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
26.415 (56/212) |
2.23E-08 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
27.861 (56/201) |
2.68E-08 |
Serine/threonine-protein kinase 35 (STK35)
|
|
24.706 (63/255) |
2.97E-08 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
25.561 (57/223) |
3.16E-08 |
Kalirin (KALRN)
|
|
26.168 (56/214) |
3.51E-08 |
Adaptor-associated kinase 1 (AAK1)
|
|
28.704 (62/216) |
4.16E-08 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
31.068 (32/103) |
5.58E-08 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
24.775 (55/222) |
6.30E-08 |
Protein kinase C zeta (PRKCZ)
|
|
21.429 (48/224) |
6.39E-08 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
25.463 (55/216) |
9.61E-08 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
24.020 (49/204) |
1.23E-07 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
25.359 (53/209) |
1.26E-07 |
Serine/threonine-protein kinase 40 (STK40)
|
|
26.627 (45/169) |
1.42E-07 |
Activin receptor type IIA (ACVR2A)
|
|
25.248 (51/202) |
1.45E-07 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
27.219 (46/169) |
1.50E-07 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
25.225 (56/222) |
1.71E-07 |
Protein kinase C iota (PRKCI)
|
|
20.543 (53/258) |
1.84E-07 |
Rhodopsin kinase GRK7 (GRK7)
|
|
24.878 (51/205) |
1.93E-07 |
Rho-associated protein kinase 2 (ROCK2)
|
|
24.402 (51/209) |
2.58E-07 |
Citron Rho-interacting kinase (CIT)
|
|
26.009 (58/223) |
2.62E-07 |
Dual specificity protein kinase TTK (MPS1)
|
|
22.963 (62/270) |
2.86E-07 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
27.059 (46/170) |
2.99E-07 |
CDC-like kinase 4 (CLK4)
|
|
24.215 (54/223) |
3.26E-07 |
Bone morphogenetic protein receptor (BMPR2)
|
|
25.620 (62/242) |
3.33E-07 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
22.222 (44/198) |
3.49E-07 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
23.636 (52/220) |
4.05E-07 |
Myotonin-protein kinase (DMPK)
|
|
23.111 (52/225) |
4.71E-07 |
Large tumor suppressor homolog 2 (LATS2)
|
|
22.260 (65/292) |
4.71E-07 |
Cyclin-G-associated kinase (GAK)
|
|
25.170 (74/294) |
5.23E-07 |
Wee1-like protein kinase 2 (WEE2)
|
|
23.404 (66/282) |
5.44E-07 |
CDC-like kinase 2 (CLK2)
|
|
24.242 (56/231) |
5.48E-07 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
25.373 (51/201) |
6.02E-07 |
Cyclin-dependent kinase 8 (CDK8)
|
|
25.610 (42/164) |
7.18E-07 |
Wee1-like protein kinase (WEE1)
|
|
24.188 (67/277) |
9.79E-07 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
22.886 (46/201) |
1.14E-06 |
PIM-3 protein kinase (PIM3)
|
|
26.293 (61/232) |
1.54E-06 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
27.027 (70/259) |
1.65E-06 |
Casein kinase I gamma-3 (CSNK1G3)
|
|
28.636 (63/220) |
1.88E-06 |
Casein kinase I gamma-1 (CSNK1G1)
|
|
27.064 (59/218) |
2.22E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
24.286 (51/210) |
2.72E-06 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
28.440 (31/109) |
2.78E-06 |
Activin receptor type IIB (ACVR2B)
|
|
24.390 (50/205) |
3.97E-06 |
TGF-beta-stimulated factor 1 (STK16)
|
|
23.381 (65/278) |
4.64E-06 |
Rhodopsin kinase GRK1 (GRK1)
|
|
23.364 (50/214) |
4.95E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
24.623 (49/199) |
5.21E-06 |
Sugen kinase 110 (SBK3)
|
|
28.758 (44/153) |
9.24E-06 |
Casein kinase II alpha prime (CSNK2A2)
|
|
22.747 (53/233) |
1.14E-05 |
Tribbles homolog 2 (TRIB2)
|
|
24.870 (48/193) |
1.23E-05 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
26.316 (60/228) |
1.42E-05 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
27.564 (43/156) |
2.48E-05 |
RelA-associated inhibitor (PPP1R13L)
|
|
40.351 (23/57) |
3.00E-05 |
Casein kinase I gamma-2 (CSNK1G2)
|
|
28.378 (63/222) |
3.69E-05 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
24.365 (48/197) |
5.03E-05 |
Casein kinase II alpha (CSNK2A1)
|
|
23.767 (53/223) |
5.60E-05 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
20.982 (47/224) |
7.74E-05 |
Rho guanine nucleotide exchange factor 7 (ARHGEF7)
|
|
37.931 (22/58) |
9.56E-05 |
Casein kinase II subunit alpha 3 (CSNK2A3)
|
|
23.318 (52/223) |
2.07E-04 |
CDC-like kinase 1 (CLK1)
|
|
24.091 (53/220) |
3.04E-04 |
Peroxisomal membrane protein PEX13 (PEX13)
|
|
37.143 (26/70) |
5.24E-04 |
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
23.684 (45/190) |
1.00E-03 |
Rho guanine nucleotide exchange factor 6 (ARHGEF6)
|
|
34.483 (20/58) |
3.00E-03 |
Serine/threonine-protein kinase haspin (HASPIN)
|
|
39.623 (21/53) |
3.00E-03 |
Abl interactor 2 (ABI2)
|
|
27.451 (14/51) |
4.00E-03 |
SCY1-like protein 2 (SCYL2)
|
|
22.979 (54/235) |
4.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |